Publications
Recent high-impact publications from Rogel Cancer Center members.
|
|
Publications from members of the Cancer Biology, Cancer Genetics, Cancer Hematopoiesis & Immunology, and Developmental Therapeutics programs
|
|
Panwalkar, P.; Pratt, D.; Chung, C.; Dang, D.; Le, P.; Martinez, D.; Bayliss, J. M.; Smith, K. S.; Adam, M.; Potter, S.; Northcott, P.; Mascarenhas, L.; Shows, J.; Pawel, B.; Margol, A.; Huang, A.; Judkins, A. R.;
Venneti, S.
SWI/SNF complex heterogeneity relates with polyphenotypic differentiation, prognosis and immune response in rhabdoid tumors.
Neuro Oncol
(2020) PMID: 31912158. PMCID: PMC7283032.
Comba, A.; Dunn, P. J.; Argento, A. E.; Kadiyala, P.; Ventosa, M.; Patel, P.; Zamler, D. B.; Nunez, F. J.; Zhao, L.; Castro, M. G.; Lowenstein, P. R.
FYN tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates anti-glioma immune responses.
Neuro Oncol
(2020) PMID: 31950181. PMCID: PMC7283034.
Shankar, S.; Tien, J. C.; Siebenaler, R. F.; Chugh, S.; Dommeti, V. L.; Zelenka-Wang, S.; Wang, X. M.; Apel, I. J.; Waninger, J.; Eyunni, S.; Xu, A.; Mody, M.; Goodrum, A.; Zhang, Y.; Tesmer, J. J.; Mannan, R.; Cao, X.; Vats, P.; Pitchiaya, S.; Ellison, S. J.; Shi, J.; Kumar-Sinha, C.;
Crawford, H. C.
;
Chinnaiyan, A. M.
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.
Nat Commun
(2020) PMID: 32499547. PMCID: PMC7272436.
Knarr, M.; Avelar, R. A.; Sekhar, S. C.; Kwiatkowski, L. J.; Dziubinski, M. L.; McAnulty, J.; Skala, S.; Avril, S.; Drapkin, R.;
DiFeo, A.
miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling.
Nat Commun
(2020) PMID: 32591511. PMCID: PMC7320168.
Khoa, L. T. P.; Tsan, Y. C.; Mao, F.; Kremer, D. M.; Sajjakulnukit, P.; Zhang, L.; Zhou, B.; Tong, X.; Bhanu, N. V.; Choudhary, C.; Garcia, B. A.; Yin, L.; Smith, G. D.; Saunders, T. L.; Bielas, S. L.; Lyssiotis, C. A.; Dou, Y.
Histone
Acetyltransferase MOF Blocks Acquisition of Quiescence in Ground-State ESCs through Activating Fatty Acid Oxidation
.
Cell Stem Cell
(2020)
In process.
PMID: 32610040.
|
|
|
|
|
"The hope was, if we can find a microRNA that regulates several significant pathways driving ovarian cancer progression, that could make a great biomarker and/or a therapeutic target." -
Analisa DiFeo, Ph.D.
|
|
|
|
COLLABORATIVE PUBLICATIONS
|
|
Interdisciplinary collaborations between Basic Sciences, Cancer Control & Population Sciences, and Translational & Clinical Research members
|
|
Alumkal, J. J.; Sun, D.; Lu, E.; Beer, T. M.; Thomas, G. V.; Latour, E.; Aggarwal, R.; Cetnar, J.; Ryan, C. J.; Tabatabaei, S.; Bailey, S.; Turina, C. B.; Quigley, D. A.; Guan, X.; Foye, A.; Youngren, J. F.; Urrutia, J.; Huang, J.; Weinstein, A. S.; Friedl, V.; Rettig, M.; Reiter, R. E.; Spratt, D. E.; Gleave, M.; Evans, C. P.; Stuart, J. M.; Chen, Y.; Feng, F. Y.; Small, E. J.; Witte, O. N.; Xia, Z.
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.
Proc Natl Acad Sci U S A
(2020) PMID: 32424106. PMCID: PMC7275746.
Miklja, Z.; Yadav, V. N.; Cartaxo, R. T.; Siada, R.; Thomas, C. C.; Cummings, J. R.; Mullan, B.; Stallard, S.; Paul, A.; Bruzek, A. K.; Wierzbicki, K.; Yang, T.; Garcia, T.; Wolfe, I.; Leonard, M.; Robertson, P. L.; Garton, H. J.; Wahl, D. R.; Parmar, H. A.; Sarkaria, J. N.; Kline, C.; Mueller, S.; Nicolaides, T.; Glasser, C.; Leary, S. E. S.; Venneti, S.; Kumar-Sinha, C.; Chinnaiyan, A. M.; Mody, R.; Pai, M. P.; Phoenix, T. N.; Marini, B. L.; Koschmann, C.
Everolimus improves the efficacy of dasatinib in PDGFRalpha-driven glioma.
J Clin Invest
(2020)
In process.
PMID: 32603316.
|
|
|
|
|
The expression of specific gene sets is associated with de novo enzalutamide resistance in men with metastatic castration-resistant prostate cancer (CRPC), according to a new study.
|
|
|
|
We want to hear your feedback!
|
|
Please forward this message to your colleagues.
|
|
|
|
|
|
|
